HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION explained in plain language.

Never miss a new study

Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION trials appear

Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Weekly pill could replace daily HIV meds in major trial

Disease control Recruiting now

This study is testing if a new combination of two HIV drugs, taken just once a week, works as well and is as safe as a standard daily pill. It is for adults living with HIV-1 who have not yet started any treatment. The goal is to see if the weekly regimen can control the virus as…

Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION

Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION trials appear

Weekly pill could replace daily HIV meds in major trial